LM
SQZ

Luminus Management’s SQZ Biotechnologies Company SQZ Stock Holding History

Luminus Management’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-353,895
Closed -$5.11M – 90
2021
Q2 		$5.11M Sell
353,895
-116,112
-25% -$1.52M 0.74% 34
2021
Q1 		$6.43M Buy
+470,007
New +$9.55M 1.24% 23

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Luminus Management's SQZ Position: Q3 2021 in Review

Luminus Management sold out of SQZ Biotechnologies Company (SQZ) in Q3 2021, closing a stake of 353,895 shares — an estimated $5.11M sold.

Luminus Management first reported a position in SQZ in Q1 2021 and held it in 2 quarters. The position peaked at $6.43M in Q1 2021. 44 funds tracked by Wall St. Rank hold SQZ as of Q3 2021.

  • Luminus Management reported no remaining SQZ Biotechnologies Company position as of Q3 2021 after selling out during the quarter.
  • Luminus Management sold 353,895 SQZ Biotechnologies Company shares in Q3 2021, an estimated $5.11M.
  • Luminus Management first reported a position in SQZ Biotechnologies Company in Q1 2021 and held it in 2 quarters.
  • Luminus Management's SQZ Biotechnologies Company position peaked at $6.43M in Q1 2021.
  • 44 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2021.

Based on Luminus Management's 13F filing for Q3 2021, filed 15 Nov 2021.